Phacilitate Leaders World

Conference speakers

Conference speakers

We’re hard at work finalising the agenda and speaker panel for Phacilitate Leaders World 2019. If would like to speak or submit an abstract please get in touch with Kim Barnes.

Download our template presentation slide

Loading
  • James Adams

    James Adams

    Senior Administrative Director, Therapeutic Products Program, Cell Processing, Fred Hutch
  • Mucahit Agirtmis

    Mucahit Agirtmis

    Business Consultant, Werum ITsolutions
  • Joy Aho

    Joy Aho

    Senior Product Manager for Cell and Gene Therapy, Bio Techne
  • Luca Alberici

    Luca Alberici

    Chief Business Officer, MolMed
  • Ernesto Algaba Reyes

    Ernesto Algaba Reyes

    Partner, Mexico City, Hogan Lovells
  • Evren Alici

    Evren Alici

    CEO; Director, Cell & Gene Therapy Centre, Vycellix; Karolinska Institutet
  • Julie Allickson

    Julie Allickson

    Director, Regenerative Medicine Clinical Center, Wake Forest School of Medicine
  • Fabrisia Ambrosio

    Fabrisia Ambrosio

    Associate Professor, Department of Physical Medicine & Rehabilitation / Director of Rehabilitation, University of Pittsburgh / UPMC International
  • Kyle Annen

    Kyle Annen

    Assistant Professor, Children's Hospital of Colorado
  • Judith Arcidiacono

    Judith Arcidiacono

    International Regulatory Expert & Standards Liaison, CBER, Food and Drug Administration
  • Takashi Asada

    Takashi Asada

    Professor, Institute for Frontier Life and Medical Sciences, Kyoto University
  • Anthony Atala, MD

    Anthony Atala, MD

    Professor and Director, Wake Forest Regenerative Medicine Institute, Wake Forest School of Medicine
  • Usman Azam

    Usman Azam

    President & CEO, Tmunity Therapeutics
  • Dave Backer

    Dave Backer

    Head of Commercial Development, Gene Editing and Novel Modalities, MilliporeSigma
  • Mariah Baltezegar

    Mariah Baltezegar

    Executive Director, General Medicine, Syneos Health
  • Linda S. Barnes

    Linda S. Barnes

    Principal, Linda S. Barnes Consulting
  • Jacqueline Barry

    Jacqueline Barry

    Chief Clinical Officer, Cell and Gene Therapy Catapult
  • Oliver Bartelsen

    Oliver Bartelsen

    Global Head of Business Development and Industrial Services, Miltenyi Biotec
  • Mary Kay Bates

    Mary Kay Bates

    Senior Global Cell Culture Specialist , Laboratory Equipment, Thermo Fisher Scientific
  • Nina Bauer

    Nina Bauer

    VP Business Development, FloDesign Sonics
  • Pascale Belguise

    Pascale Belguise

    Director of Business Development, Polyplus Transfection
  • Reni Benjamin

    Reni Benjamin

    Managing Director, Biotechnology Equity Research, Raymond James & Associates, Inc
  • Alexey Bersenev

    Alexey Bersenev

    Director, Cell Therapy Labs, Yale-New Haven Hospital, Yale University
  • Ravi Bhatia

    Ravi Bhatia

    Scientific Director, Johnson & Johnson
  • Barbara Binzak Blumenfeld

    Barbara Binzak Blumenfeld

    Shareholder / Member, Buchanan Ingersoll & Rooney PC / AARM Ethics and Policy Committee
  • John Bishai

    John Bishai

    Director, Healthcare Investment Banking, Wells Fargo Securities
  • Tony Bizou Liu

    Tony Bizou Liu

    Executive Director, CEO, CFO, Cellular Biomedicine Group
  • Greg Bonfiglio

    Greg Bonfiglio

    Founder & Managing Partner, Proteus, LLC
  • Maria Bonneville

    Maria Bonneville

    Vice President of Administration, Executive Director to the CIRM Governing Board, Californian Institute of Regenerative Medicine
  • Steven Breazzano, PhD

    Steven Breazzano, PhD

    Analyst, Casdin Capital
  • Kelvin Brockbank

    Kelvin Brockbank

    Research Professor of Bioengineering / Adjunct Professor, Department of Regenerative Medicine & Cell Biology, Clemson University / Medical University of South Carolina
  • Bruce Bunnell

    Bruce Bunnell

    Professor & Director, Tulane Center for Stem Cell Research & Regenerative Medicine, Tulane University
  • Terry Burns

    Terry Burns

    Neurosurgeon, Mayo Clinic
  • Lambert Busque

    Lambert Busque

    Chief Medical Officer, C3i
  • Cynthia Cai

    Cynthia Cai

    Senior Advisor, US Lead in Healthcare, Northern Light Venture Capital
  • Neil Canavan

    Neil Canavan

    Scientific Advisor, Solebury Trout
  • Arnold Caplan, PhD

    Arnold Caplan, PhD

    Professor of Biology and Director of the Skeletal Research Center, Case Western Reserve University
  • Jessica Carmen

    Jessica Carmen

    Consultant, Pullan Consulting
  • Michael Carstens

    Michael Carstens

    Professor of Plastic Surgery / Instructor / Director of Surgical Research, National University of Nicaragua / Wake Forest University Institute of Regenerative Medicine / Asociación Pro Niños Quemados de Nicaragua (APROQUEN)
  • Joy Cavagnaro

    Joy Cavagnaro

    President, Access BIO
  • Christina Celluzzi

    Christina Celluzzi

    Senior Manager, Cellular Therapies, AABB Center for Cellular Therapies
  • Massimiliano Cesarini

    Massimiliano Cesarini

    Sales Manager - Isolation Technology Division, Comecer
  • Kyle J. Cetrulo

    Kyle J. Cetrulo

    Co-Founder & CEO / President & Founder, Auxocell Laboratories, Inc / Perinatal Stem Cells Society
  • Theresa Chen

    Theresa Chen

    Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), Office of Tissues and Advanced Therapies (OTAT) Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA)
  • Li Chen

    Li Chen

    Head of Human Liver Cell Lab, UCSD
  • Vijay Chiruvulu

    Vijay Chiruvulu

    VP of Global Process Development - Cell Therapy, Kite Pharma (A Gilead Company)
  • Sung Hyun Choi

    Sung Hyun Choi

    Principal Research Scientist, Daewoong Pharmaeutical Co Ltd.
  • George Christ

    George Christ

    Professor of Biomedical Engineering & Orthopaedic Surgery, Mary Muilenberg Stamp Professor of Orthopaedic Research, Director of Basic and Translational Research in Orthopaedic Surgery, University of Virginia

 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK